Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UK debates asbestos-related diseases compensation, heralds a new healthcare focus?

This article was originally published in Clinica

Executive Summary

The UK parliament took a further step towards better addressing the needs of asbestos-related diseases (ARDs), with further debate of draft legislation on compensating pleural plaques and asbestosis. The issue of compensation is relevant to the development of medical research and healthcare in this area, in that a greater willingness to recognise exposure will impact on assessing and meeting healthcare demand.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT043723

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel